Hypertrophy and Liver Function in ALPPS: Correlation with Morbidity and Mortality | Zendy

Danby Kang | Zendy; Erik Schadde | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hypertrophy and Liver Function in ALPPS: Correlation with Morbidity and Mortality

Author(s) -

Danby Kang,

Erik Schadde

Publication year - 2017

Publication title -

visceral medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.598

H-Index - 17

eISSN - 2297-475X

pISSN - 2297-4725

DOI - 10.1159/000479477

Subject(s) - hepatectomy , liver failure , medicine , incidence (geometry) , liver function , muscle hypertrophy , gastroenterology , liver regeneration , surgery , resection , biology , mathematics , geometry , regeneration (biology) , microbiology and biotechnology

ALPPS (associating liver partition and portal vein ligation for staged hepatectomy) was introduced with the promise to reduce posthepatectomy liver failure (PHLF) in extended hepatectomies but has higher morbidity and mortality rates compared to conventional methods of volume enhancement. There are few studies of the incidence of PHLF after ALPPS and little information on how to avoid PHLF by functional testing. It remains unclear what causes the compromise in liver function despite rapid volume gain and if any of the modifications proposed reduce the incidence of PHLF. This review summarizes published data on this topic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research